AstraZeneca Sues Mylan Over Nexium Patents
AstraZeneca AB on Wednesday sued Mylan Laboratories Ltd. in New Jersey federal court for allegedly relying on AstraZeneca patents to make a generic version of Nexium, its latest infringement complaint over...To view the full article, register now.
Already a subscriber? Click here to view full article